Literature DB >> 9238324

The pathogenesis of alopecia areata.

A J McDonagh1, A G Messenger.   

Abstract

Knowledge of the disease mechanisms in alopecia areata is discussed in the light of progress in hair biology, immunology, and genetics. A disease model is presented incorporating polygenic determination of disease severity and susceptibility with largely unknown trigger factors responsible for initiating clinical disease expression. Experimental systems including animal models for alopecia areata offer new opportunities for investigation of alopecia areata and developing novel therapies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9238324     DOI: 10.1016/s0733-8635(05)70392-2

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  11 in total

Review 1.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Skin disorders and thyroid diseases.

Authors:  H Niepomniszcze; R H Amad
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

3.  Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

Authors:  Enas A S Attia; Dina El Shennawy; Ashraf Sefin
Journal:  Dermatol Res Pract       Date:  2010-06-30

4.  Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata.

Authors:  Cm Kuldeep; Himanshu Singhal; Ashok Kumar Khare; Asit Mittal; Lalit K Gupta; Anubhav Garg
Journal:  Int J Trichology       Date:  2011-01

5.  A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata.

Authors:  Tueboon Sriphojanart; Saranya Khunkhet; Poonkiat Suchonwanit
Journal:  Dermatol Reports       Date:  2017-11-30

6.  Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.

Authors:  Katarzyna Tabara; Magdalena Kozłowska; Anna Jędrowiak; Wojciech Bienias; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

7.  Evaluation of utility of phenol in alopecia areata.

Authors:  Siddhi Chikhalkar; Hemangi Jerajani; Bhushan Madke
Journal:  Int J Trichology       Date:  2013-10

8.  Comparison of zn, cu, and fe content in hair and serum in alopecia areata patients with normal group.

Authors:  Ladan Dastgheib; Zohreh Mostafavi-Pour; Ahmad Adnan Abdorazagh; Zahra Khoshdel; Maryam Sadat Sadati; Iman Ahrari; Sajjad Ahrari; Mahsa Ghavipisheh
Journal:  Dermatol Res Pract       Date:  2014-08-27

9.  Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.

Authors:  Florian Anzengruber; Julia-Tatjana Maul; Jivko Kamarachev; Ralph M Trüeb; Lars E French; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2016-04-22

Review 10.  Immune surveillance in the skin: mechanisms and clinical consequences.

Authors:  Thomas S Kupper; Robert C Fuhlbrigge
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.